An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism. (Q34201444)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12776264%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

0 references

1 reference

title

An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12776264%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12776264%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Carlo Manno

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12776264%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Francesco P Schena

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12776264%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12776264%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12776264%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12776264%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12776264%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1129-1139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12776264%20AND%20SRC:MED&resulttype=core&format=json

Immunoglobulin a nephropathy with mild renal lesions: a call in the forest for physicians and nephrologists

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900344-5

7 January 2021

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900344-5

7 January 2021

Corticosteroids in IgA nephropathy: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900344-5

7 January 2021

Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900344-5

7 January 2021

A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900344-5

7 January 2021

10.1016/S0272-6386(03)00344-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12776264%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference